CONMED Price to Free Cash Flow Ratio 2010-2024 | CNMD
Historical price to free cash flow ratio values for CONMED (CNMD) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| CONMED Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-11-06 |
75.64 |
|
14.90 |
| 2024-06-30 |
69.14 |
$5.08 |
13.62 |
| 2024-03-31 |
79.64 |
$4.50 |
17.72 |
| 2023-12-31 |
108.64 |
$3.37 |
32.24 |
| 2023-09-30 |
99.87 |
$1.19 |
84.19 |
| 2023-06-30 |
134.32 |
$0.50 |
267.35 |
| 2023-03-31 |
102.51 |
$0.22 |
463.00 |
| 2022-12-31 |
87.30 |
$0.39 |
226.45 |
| 2022-09-30 |
78.77 |
$1.87 |
42.06 |
| 2022-06-30 |
93.89 |
$1.78 |
52.85 |
| 2022-03-31 |
145.34 |
$2.30 |
63.21 |
| 2021-12-31 |
138.49 |
$3.01 |
46.04 |
| 2021-09-30 |
127.62 |
$2.64 |
48.38 |
| 2021-06-30 |
133.85 |
$3.21 |
41.69 |
| 2021-03-31 |
127.00 |
$2.33 |
54.48 |
| 2020-12-31 |
108.75 |
$1.75 |
62.19 |
| 2020-09-30 |
76.24 |
$2.36 |
32.27 |
| 2020-06-30 |
69.61 |
$2.34 |
29.69 |
| 2020-03-31 |
55.22 |
$2.85 |
19.38 |
| 2019-12-31 |
107.52 |
$2.55 |
42.25 |
| 2019-09-30 |
92.28 |
$2.05 |
44.91 |
| 2019-06-30 |
81.96 |
$0.98 |
83.68 |
| 2019-03-31 |
79.48 |
$1.00 |
79.68 |
| 2018-12-31 |
61.19 |
$2.01 |
30.38 |
| 2018-09-30 |
75.28 |
$1.93 |
39.09 |
| 2018-06-30 |
69.39 |
$2.75 |
25.28 |
| 2018-03-31 |
59.87 |
$2.61 |
22.90 |
| 2017-12-31 |
48.03 |
$2.21 |
21.77 |
| 2017-09-30 |
49.25 |
$2.38 |
20.67 |
| 2017-03-31 |
41.37 |
$2.05 |
20.15 |
| 2016-12-31 |
40.94 |
$0.90 |
45.56 |
| 2016-09-30 |
36.97 |
$0.88 |
42.20 |
| 2016-06-30 |
43.83 |
$0.45 |
98.35 |
| 2016-03-31 |
38.33 |
$0.20 |
187.17 |
| 2015-12-31 |
40.07 |
$1.29 |
31.09 |
| 2015-09-30 |
43.21 |
$1.78 |
24.23 |
| 2015-06-30 |
52.54 |
$1.83 |
28.78 |
| 2015-03-31 |
45.37 |
$1.26 |
35.96 |
| 2014-12-31 |
40.24 |
$-0.43 |
0.00 |
| 2014-09-30 |
32.82 |
$-0.46 |
0.00 |
| 2014-06-30 |
39.14 |
$0.05 |
754.12 |
| 2017-06-30 |
47.63 |
$0.87 |
54.76 |
| 2013-12-31 |
37.34 |
$2.22 |
16.80 |
| 2013-09-30 |
29.69 |
$3.55 |
8.37 |
| 2013-06-30 |
27.18 |
$3.11 |
8.75 |
| 2013-03-31 |
29.50 |
$3.44 |
8.58 |
| 2012-12-31 |
24.10 |
$4.11 |
5.87 |
| 2014-03-31 |
38.35 |
$2.04 |
18.78 |
| 2012-09-30 |
24.44 |
$2.32 |
10.54 |
| 2012-06-30 |
23.60 |
$2.64 |
8.92 |
| 2012-03-31 |
25.33 |
$2.45 |
10.34 |
| 2011-12-31 |
21.66 |
$2.98 |
7.26 |
| 2011-09-30 |
19.41 |
$2.90 |
6.69 |
| 2011-06-30 |
24.03 |
$1.96 |
12.23 |
| 2011-03-31 |
22.17 |
$1.94 |
11.41 |
| 2010-12-31 |
22.30 |
$0.81 |
27.42 |
| 2010-09-30 |
18.91 |
$-0.02 |
0.00 |
| 2010-06-30 |
15.72 |
$-0.00 |
0.00 |
| 2010-03-31 |
20.09 |
$-0.41 |
0.00 |
| 2009-12-31 |
19.24 |
$0.12 |
156.39 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.337B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
